Congress Materials – Fall Clinical 2024

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

FREQUENCY AND PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS AND OTHER COMORBIDITIES IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS FROM THE VISIBLE TRIAL

L. Stein Gold, G. Han, M. Shahriari, T. Bhutani, O. Choi, T. Alkousakis, K. Rowland, A. Rodriguez, G. Yadav, J. Yeung, T. Ma, L.-L. Gao, D. Chan, L. Green, A.S. Farberg, S. Kwatra, A. Alexis

 

View poster

Insights on Oral Therapies for Psoriasis: A Medical Science Liaison Administered Questionnaire

Jeff Pawlikowski; Kush Shah; Dianne Bogdan; Katelyn Rowland; LaTanya Pearson; Daphne Chan; Victor Czerkasij; Nicole Seminara

 

View poster

SHADOWS OF INFLAMMATION: EXPLORING POST-INFLAMMATORY PIGMENT CHANGES IN PSORIASIS IN VISIBLE, A PHASE 3b RANDOMIZED CONTROLLED STUDY OF GUSELKUMAB FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS DEDICATED TO PEOPLE OF COLOR

A Alexis, A McMichael, T Bhutani, M Shahriari, O Choi, T Alkousakis, K Rowland, A Rodriguez, G Yadav, J Yeung, T Ma, N Abbarin, D Chan, C Kindred, N Vashi, P Grimes, S Desai, S Taylor

 

View poster

SPECTREM: Guselkumab Demonstrates Consistent Complete Clearance at Week 16 Across Special Sites in Participants with Low Body Surface Area, Moderate Psoriasis

BP Glick, J Beecker, J Alonso-Llamazares, A Moore, T Alkousakis, K Shah, O Choi, D Chan, L Park-Wyllie, J Jeyarajah, K Rowland, G Yadav, HCH Hong

 

View poster

SPECTREM: Guselkumab Demonstrates Consistent Significant Clearance at Week 16 Across the Full Range of Low Body Surface Area, Moderate Psoriasis with Special Sites Involvement

L Stein Gold, B Strober, AW Armstrong, T Alkousakis, KA Papp, R Langley, O Choi, D Chan, J Jeyarajah, V Groysman, MG Lebwohl

 

View poster

SPECTREM: Guselkumab Demonstrates Significant Clearance at Week 16 Across Special Sites in Participants with Low Body Surface Area, Moderate Psoriasis

AB Gottlieb, J Krueger, KB Gordon, R Bissonnette, T Alkousakis, O Salgado, O Choi, D Chan, J Jeyarajah, J Garcia-Zuazaga, JF Merola

 

View poster

SPECTREM: Guselkumab Significantly Improves Patient Reported Outcomes at Week 16 in Participants with Low Body Surface Area Moderate Psoriasis with Special Site Involvement

J Soung, V Kelly, M Wiseman, AO Rodriguez, T Alkousakis, O Choi, D Chan, K Rowland, J Jeyarajah, N Abbarin, E Skobelev, S Ramji, J Krell, M Sauder, DN Adam

 

View poster

Sustained Improvements in Psoriasis Area and Severity Index and in Percent Body Surface Area of Psoriasis With JNJ-77242113 in Patients With Moderate-to-Severe Plaque Psoriasis: Treat-to-Target Analyses in the FRONTIER 1 & 2 Studies

Kim A. Papp, Laura K. Ferris, Andreas Pinter, Phoebe Rich, Ronald B. Vender, Andrew E. Pink, Takayuki Ota, Yaung-Kaung Shen, Shu Li, Amy M. DeLozier, Ya-Wen Yang, Robert Bissonnette

 

View poster

THE POWER OF IMAGERY IN CLINICAL MEDICINE: LEVERAGING CLINICAL PHOTOS FROM THE VISIBLE STUDY TO FOSTER CONVERSATIONS BETWEEN CLINICIANS AND PATIENTS

AO Rodriguez, L Stein Gold, M Shahriari, A Alexis, O Choi, D Chan, T Alkousakis, E Skobelev, S Ramji, A McMichael, S Taylor, S Desai

 

View poster

VISIBLE COHORT A: SKIN CLEARANCE THROUGH WEEK 48 WITH GUSELKUMAB IN PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS ACROSS ALL SKIN TONES

A. Alexis, A.O. Rodriguez, G. Yadav, S.K. Tyring, O. Choi, T. Alkousakis, D. Chan, T. Ma, M. Sauder, J. Alonso-Llamazares, S.R. Desai

 

View poster

VISIBLE COHORT B: SCALP CLEARANCE THROUGH WEEK 48 WITH GUSELKUMAB IN PARTICIPANTS WITH MODERATE-TO-SEVERE SCALP PSORIASIS ACROSS ALL SKIN TONES

A. McMichael, T. Bhutani, S. Smith, T. Alkousakis, O. Choi, D. Chan, T. Ma, R. Radusky, J. Yeung, G. Han, S.C. Taylor

 

View poster